The drug gevilon that produces hypolipidemic effects has been clinical
ly tested. The drug was used to treat 53 patients suffering from coron
ary heart disease, hypertensive disease with severe lipid metabolic di
sturbances. Gevilon has been found to have a hypolipidemic effect in r
educing the levels of total cholesterol, beta-cholesterol, triglycerid
es, increasing alpha-cholesterol levels and normalizing the atherogeni
city coefficient. The hypolipidemic effect of the drug is the most pro
nounced in Type IIb dyslipoproteinemia. Gevilon is well. tolerated by
patients, it can be used in combination with the drugs given in the co
mplex therapy for coronary heart disease and hypertension.